COMBINATION OF A PD-1 ANTAGONIST AND AN IDO1 INHIBITOR FOR TREATING CANCER

• 收藏
• 分享

专利权人:

Incyte Corporation

发明人:

LEOPOLD, Lance,KAUFMAN, David

申请号：

EP15746743

公开号：

EP3102237A4

申请日:

2015.02.03

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and a selective inhibitor of indoleamine 2, 3-dioxygenase 1 (IDO1), and the use of the combination therapies for the treatment of cancer, and in particular for treating cancers that express PD-L1.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/